Production of coronavirus drugs in the European Union, including the Russian vaccine, is theoretically acceptable under certification by the European Medicines Agency (EMA). This statement was made by Ulrike Demmer, deputy official representative of the German Cabinet of Ministers.

However, a representative of the German Ministry of Health was unable to specify whether EMA had received such a request.

Earlier, the press service of the Kremlin reported that the Russian president during a telephone conversation with the chancellor of Germany discussed the fight against infection "with an emphasis on possible prospects for joint production of vaccines."

Demmer said the chancellor made it clear during the conversation that Germany was willing to cooperate "with a view to developing European production capacity."

The EMA said in November that it was in dialogue with the developer of the Russian vaccine and was discussing further collaboration. However, the agency pointed out that it is difficult to predict the likely timing of approvals for the drug.

Made in Russia // Made in Russia

Author: Ksenia Gustova